Use case

Discover the FormularyDecisions® Biosimilar Hub

The biosimilars market is growing rapidly, but navigating this evolving landscape can be complex for healthcare decision-makers (HCDMs). Cencora’s industry-recognized FormularyDecisions Biosimilar Hub streamlines the decision-making process by consolidating essential biosimilar information in one easy-to-use platform.
Doctor using a tablet
Doctor using a tablet
This innovative hub empowers HCDMs with tools to:
  • Stay updated on biosimilar approvals, launches, and pipeline developments.
  • Access clinical efficacy and safety data to support evidence-based decisions.
  • Explore therapeutic options with an intuitive indication tool.
  • Navigate state-specific substitution laws with ease.

Recognized for its excellence in pharmaceutical education, the Biosimilar Hub adopts a systematic, patient-first approach to simplify biosimilar research, improve patient outcomes, and reduce healthcare costs.

Explore how the FormularyDecisions Biosimilar Hub can help you make informed, trusted decisions for your organization and patients. Download the use case below:
Doctor using a tablet
* Available in English only.

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.

Related resources

Article

AI-powered tools for pricing: Key takeaways from ISPOR Europe 2025

Article

Rethinking oncology launches: How the next generation of patients is reshaping strategies

Article

The transformative potential of AI in supporting health economic modeling